Tilray (NASDAQ:TLRY) Stock Price Up 0.2%

Tilray Inc (NASDAQ:TLRY)’s stock price rose 0.2% on Thursday . The stock traded as high as $1.81 and last traded at $1.79. Approximately 4,541,351 shares changed hands during trading, a decline of 82% from the average daily volume of 25,724,287 shares. The stock had previously closed at $1.79.

Analyst Ratings Changes

TLRY has been the topic of several research analyst reports. Alliance Global Partners lifted their target price on Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a research note on Friday, April 5th. Canaccord Genuity Group dropped their price objective on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Finally, CIBC dropped their price objective on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th.

Tilray Trading Up 2.8 %

The company’s 50 day simple moving average is $1.78 and its two-hundred day simple moving average is $1.90. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.92 and a quick ratio of 1.18.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Simplicity Wealth LLC acquired a new position in shares of Tilray during the 1st quarter worth $28,000. RPO LLC acquired a new position in shares of Tilray during the 4th quarter worth $28,000. Gainplan LLC acquired a new position in shares of Tilray during the 4th quarter worth $28,000. Wellington Wealth Strategies LLC. acquired a new position in shares of Tilray during the 4th quarter worth $29,000. Finally, International Assets Investment Management LLC increased its stake in shares of Tilray by 179.0% during the 4th quarter. International Assets Investment Management LLC now owns 14,734 shares of the company’s stock worth $34,000 after purchasing an additional 9,453 shares during the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.